Public Market Listing
4523TSE
Live quotes, historical charts, and market capitalization for Eisai are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(9 total)
9Total Assets
5Approved
2Phase 3 / Filed
2Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | Tubulin / microtubulesSmall molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
Lecanemab(Leqembi) | Approved | Amyloid-beta (monoclonal antibody)Monoclonal antibody | Alzheimer's Disease |
Perampanel(Fycompa) | Approved | AMPA receptor (antagonist) · AMPA receptor (positive allosteric modulator)Small molecule | Epilepsy |
| Approved | Voltage-gated sodium channelSmall molecule | Epilepsy | |
| Approved | Voltage-gated sodium channelsSmall molecule | Epilepsy | |
| Phase 3 | Undisclosed / early pipeline | Rheumatoid Arthritis | |
Lemborexant(Dayvigo) | Phase 3 | Orexin receptor (repositioned)Small molecule | Alzheimer's Disease |
| Phase 2/3 | Tau (monoclonal antibody)Monoclonal antibody | Alzheimer's Disease | |
| Phase 1/2 | Estrogen receptor alpha (covalent antagonist)Small molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.